Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

COGT

Cogent Biosciences, Inc.

CIK 0001622229 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$40.51
↑ 0.54 (1.35%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$6.92B
P/E Ratio
-19.54
EPS
-2.16
Dividend Yield
Not covered
52W Position
91%
Beta
2.45

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
11.39
P/S
Not covered
EV/Revenue
Not covered
ROE
-58.3%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 91%
$9.25$43.73

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$328.94M
Total Assets
$937.61M
Free Cash Flow
-$266.00M

Recent news